Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

EU has exported over 1 billion COVID-19 vaccines, von der Leyen says

Published 10/18/2021, 05:32 AM
Updated 10/18/2021, 11:43 AM
© Reuters. FILE PHOTO: A woman holds a small bottle labelled with a "Coronavirus COVID-19 Vaccine" sticker and a medical syringe in this illustration taken  October 30, 2020. REUTERS/Dado Ruvic

© Reuters. FILE PHOTO: A woman holds a small bottle labelled with a "Coronavirus COVID-19 Vaccine" sticker and a medical syringe in this illustration taken October 30, 2020. REUTERS/Dado Ruvic

By Francesco Guarascio

BRUSSELS (Reuters) -More than a billion COVID-19 vaccines produced in the European Union have been exported since December 2020, making the bloc the biggest exporter of the shots, European Commission head Ursula von der Leyen said on Monday.

The vaccines had gone to more than 150 countries, and the EU had exported as many doses as it had distributed to its own citizens, von der Leyen added in a statement.

The bloc started exporting vaccines at the start of the global roll out at a time when other major producers such as the United States were building up their own supplies and restricting exports.

Most EU exports have been directed to bigger economies, including Japan, Turkey and Britain, who had contracts with vaccine makers based in the bloc.

Sales and donations to poorer nations have so far made up a small proportion of total exports, but the bloc was planning to distribute at least 500 million shots to the most vulnerable countries in coming months, von der Leyen said.

Half of these doses would be supplied from a new contract that the EU wants to have with a producer of messenger RNA vaccines, officials said. The other half will be donations from EU states who have already bought vaccines.

The bloc has already signed supply contracts with mRNA vaccine makers Pfizer-BioNTech for a total of up to 2.4 billion doses until 2023 and with Moderna (NASDAQ:MRNA) for up to 460 million doses.

© Reuters. European Commission President Ursula von der Leyen gives a media statement on the coronavirus disease (COVID-19) vaccines, in Brussels, Belgium October 18, 2021.  REUTERS/Yves Herman/Pool

The EU set up a vaccine export control mechanism in late January to monitor the outbound flow of shots from the continent.

Although the mechanism allows the EU to block exports in the event of insufficient domestic supplies, it has been activated only once to prevent the shipment of 250,000 AstraZeneca (NASDAQ:AZN) vaccines to Australia in March at the height of a dispute with the Anglo-Swedish firm about its supplies to the EU.

Latest comments

it's great to see the whole world embrace these American drugs from these crooked companies I guess people like Americans more than what they say they do how about that
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.